Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin

Muscle and Nerve

Volumn 42, Issue 3, 2010, Pages 445-448

  Terracciano, Chiara ^a   Fiore, Stefania ^a   Doldo, Elena ^a   Manzari, Vittorio ^a   Marfia, Girolama Alessandra ^a   Bernardi, Giorgio ^a   Massa, Roberto ^a   Albonici, Loredana ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Acute polyneuropathy; IVIg; POEMS; sVEGFR2; VEGF

Indexed keywords

IMMUNOGLOBULIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CASE REPORT; CORRELATION ANALYSIS; DEMYELINATION; EDEMA; FOLLOW UP; HUMAN; MALE; POEMS SYNDROME; PRIORITY JOURNAL; REMISSION;

ACTION POTENTIALS; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MOTOR NEURONS; MUSCLE, SKELETAL; PELVIC NEOPLASMS; PLASMACYTOMA; POEMS SYNDROME; SENSORY RECEPTOR CELLS; THROMBOCYTOSIS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77956045279     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21718     Document Type: Article

References (14)

1. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996;347:702. (Pubitemid 26076167)
2. Dispenzieri A. POEMS syndrome. Blood Rev 2007;21:285-299.
3. Dyck PJ, Engelstad JN, Dispenzieri A. Vascular endothelial growth factor and POEMS. Neurology 2006;66:10-12. (Pubitemid 43739583)
4. Ruiz de Almodovar C, Lambreechts D, Mazzone M, Carmeliet P. Role and therapeutic potential of VEGF in nervous system. Physiol Rev 2009;89:607-648.
5. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 2006;7:359-371.
6. Ebos JML, Bocci G, Man S, Thorpe PE, Hickland DJ, Zhou D, et al. A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma. Mol Cancer Res 2004;2:315-326. (Pubitemid 39025294)
7. van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC. A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet 2007;6:589-594. (Pubitemid 46921042)
8. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res 2000;6:3147-3152.
9. Nobile-Orazio E, Terenghi F, Giannotta C, Gallia F, Nozza A. Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies. Neurology 2009;72:1024-1026.
10. Svenson M, Hansen MB, Bendtzen K. Binding of cytokines to pharmaceutically prepared human immunoglobulin. J Clin Invest 1993;92:2533-2539. (Pubitemid 23333564)
11. Giraudo E, Primo L, Audero E, Gerber H-P, Koolwijk P, Soker S, et al. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J Biol Chem 1998;273:22128-22135. (Pubitemid 28405397)
12. Swendeman S, Mendelson K, Weskamp G, Horiuchi K, Deutsch U, Schere P, et al. VEGF-A stimulates ADAM-17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circ Res 2008;103:916-918.
13. Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R, et al. Polyneuropathy in POEMS syndrome: role of the angiogenic factors in the pathogenesis. Brain 2005;128:1911-1920. (Pubitemid 41373663)
14. Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 2005;14:207-221. (Pubitemid 41661355)